8 research outputs found

    STOPPING AND RESUMING: HOW AND WHY DO PEOPLE SEARCH ACROSS SESSIONS FOR COMPLEX TASKS?

    Get PDF
    Cross-session searches (XSS) occur when people look for information online for multiple sessions to complete complex task goals over time. Previous studies explored aspects of XSS, including the reasons that lead to it, like the Multiple Information Seeking Episode (MISE) model, which highlights eight causes. However, less is known about how these reasons manifest in real-life XSS and their relationship with task characteristics. I conducted a diary study with 25 participants engaging in XSS for real-life tasks. Participants reported on at least three search sessions spanning at least two days, and 15 participants attended an interview after they completed the diary study. We used qualitative methods to explore motivations for expected XSS, goal complexity, session resuming and stopping reasons, types of found information, cognitive activities, and the non-search task activities that happened during the XSS process. Our results validated and refined the MISE session resuming and stopping reasons and distinguished subcategories and reasons unique to real-life XSS tasks. We discerned task-oriented and cognition-oriented motivations for XSS. We identified seven types of non-search task activities and three popular modes describing how people intertwine search and non-search activities during XSS. We assessed relationships among factors, including session goal complexity, information types, cognitive activities, session resuming, and stopping reasons using quantitative methods. Our results show significant associations between information types, cognitive activities, session goal complexity, and session resuming and stopping reasons. Furthermore, task stages significantly correlate with perceived overall task difficulty and the difficulty to find enough information. We also identified five XSS-specific challenges. Our results have implications for tailoring future search engines to customize search results according to session resuming reasons and designing tools to assist task management and preparation for session stops. Methodologically, our results have insights into designing tasks and subtasks and controlling the reasons that can lead to successive searches for tasks with varying complexity.Doctor of Philosoph

    Front-Line Physicians' Satisfaction with Information Systems in Hospitals

    Get PDF
    Day-to-day operations management in hospital units is difficult due to continuously varying situations, several actors involved and a vast number of information systems in use. The aim of this study was to describe front-line physicians' satisfaction with existing information systems needed to support the day-to-day operations management in hospitals. A cross-sectional survey was used and data chosen with stratified random sampling were collected in nine hospitals. Data were analyzed with descriptive and inferential statistical methods. The response rate was 65 % (n = 111). The physicians reported that information systems support their decision making to some extent, but they do not improve access to information nor are they tailored for physicians. The respondents also reported that they need to use several information systems to support decision making and that they would prefer one information system to access important information. Improved information access would better support physicians' decision making and has the potential to improve the quality of decisions and speed up the decision making process.Peer reviewe

    Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

    Get PDF
    The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously published treatment guidelines for bipolar disorder in 2005, along with international commentaries and subsequent updates in 2007, 2009, and 2013. The last two updates were published in collaboration with the International Society for Bipolar Disorders (ISBD). These 2018 CANMAT and ISBD Bipolar Treatment Guidelines represent the significant advances in the field since the last full edition was published in 2005, including updates to diagnosis and management as well as new research into pharmacological and psychological treatments. These advances have been translated into clear and easy to use recommendations for first, second, and third- line treatments, with consideration given to levels of evidence for efficacy, clinical support based on experience, and consensus ratings of safety, tolerability, and treatment-emergent switch risk. New to these guidelines, hierarchical rankings were created for first and second- line treatments recommended for acute mania, acute depression, and maintenance treatment in bipolar I disorder. Created by considering the impact of each treatment across all phases of illness, this hierarchy will further assist clinicians in making evidence-based treatment decisions. Lithium, quetiapine, divalproex, asenapine, aripiprazole, paliperidone, risperidone, and cariprazine alone or in combination are recommended as first-line treatments for acute mania. First-line options for bipolar I depression include quetiapine, lurasidone plus lithium or divalproex, lithium, lamotrigine, lurasidone, or adjunctive lamotrigine. While medications that have been shown to be effective for the acute phase should generally be continued for the maintenance phase in bipolar I disorder, there are some exceptions (such as with antidepressants); and available data suggest that lithium, quetiapine, divalproex, lamotrigine, asenapine, and aripiprazole monotherapy or combination treatments should be considered first-line for those initiating or switching treatment during the maintenance phase. In addition to addressing issues in bipolar I disorder, these guidelines also provide an overview of, and recommendations for, clinical management of bipolar II disorder, as well as advice on specific populations, such as women at various stages of the reproductive cycle, children and adolescents, and older adults. There are also discussions on the impact of specific psychiatric and medical comorbidities such as substance use, anxiety, and metabolic disorders. Finally, an overview of issues related to safety and monitoring is provided. The CANMAT and ISBD groups hope that these guidelines become a valuable tool for practitioners across the globe

    Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder

    Get PDF
    The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously published treatment guidelines for bipolar disorder in 2005, along with international commentaries and subsequent updates in 2007, 2009, and 2013. The last two updates were published in collaboration with the International Society for Bipolar Disorders (ISBD). These 2018 CANMAT and ISBD Bipolar Treatment Guidelines represent the significant advances in the field since the last full edition was published in 2005, including updates to diagnosis and management as well as new research into pharmacological and psychological treatments. These advances have been translated into clear and easy to use recommendations for first, second, and third- line treatments, with consideration given to levels of evidence for efficacy, clinical support based on experience, and consensus ratings of safety, tolerability, and treatment-emergent switch risk. New to these guidelines, hierarchical rankings were created for first and second- line treatments recommended for acute mania, acute depression, and maintenance treatment in bipolar I disorder. Created by considering the impact of each treatment across all phases of illness, this hierarchy will further assist clinicians in making evidence-based treatment decisions. Lithium, quetiapine, divalproex, asenapine, aripiprazole, paliperidone, risperidone, and cariprazine alone or in combination are recommended as first-line treatments for acute mania. First-line options for bipolar I depression include quetiapine, lurasidone plus lithium or divalproex, lithium, lamotrigine, lurasidone, or adjunctive lamotrigine. While medications that have been shown to be effective for the acute phase should generally be continued for the maintenance phase in bipolar I disorder, there are some exceptions (such as with antidepressants); and available data suggest that lithium, quetiapine, divalproex, lamotrigine, asenapine, and aripiprazole monotherapy or combination treatments should be considered first-line for those initiating or switching treatment during the maintenance phase. In addition to addressing issues in bipolar I disorder, these guidelines also provide an overview of, and recommendations for, clinical management of bipolar II disorder, as well as advice on specific populations, such as women at various stages of the reproductive cycle, children and adolescents, and older adults. There are also discussions on the impact of specific psychiatric and medical comorbidities such as substance use, anxiety, and metabolic disorders. Finally, an overview of issues related to safety and monitoring is provided. The CANMAT and ISBD groups hope that these guidelines become a valuable tool for practitioners across the globe

    Adolescent lifestyle and depressive symptoms: associations and complex community determinants

    Full text link
    &nbsp;This research explored adolescents&rsquo; lifestyle behaviours and depressive symptoms. Adolescents who were inactive and ate unhealthy diets reported more depressive symptoms than their healthier peers. Community stakeholders identified that lifestyle behaviours were complex and driven by various socio-cultural factors. These factors can inform new strategies to improve adolescents&rsquo; mental health.<br /

    Catalogue of the public documents of the 54th Congress, 1st session and of all departments of the Government of the United States for the period from July 1, 1895, to June 30, 1896.

    Get PDF
    Catalogue of Public Documents. 1 Nov. HD 355, 54-2, v76, 692p. [3552] For the 54th Congress, 1st session; U.S. publications on Indians are listed
    corecore